Endoxifen is a new potent inhibitor of PKC: A potential therapeutic agent for bipolar disorder
References and notes (11)
- et al.
Biol. Psychiatry
(1993) - et al.
Biol. Psychiatry
(2006)et al.Neuroscience
(2001) - et al.
Psychoneuroendocrinology
(2006)et al.Arch. Gen. Psychiatry
(2000) - et al.
Arch. Gen. Psychiatry
(2008)et al.Bipolar Disord.
(2007) - et al.
Curr. Psychiatry Rep.
(2008)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2010 Elsevier Ltd. All rights reserved.